CLINICAL_TRIALS
trial_result
· 2020-01-09
Clinical Trial Update: Effectiveness Study of Nivolumab Compared to Chemotherapy in Patients With Relapsed Small-cell Lung Cancer [Phase 3]
Summary
A Phase 3 trial comparing nivolumab to chemotherapy in relapsed small-cell lung cancer has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2020-01-09